DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5df897/notch_signaling_pa) has announced the addition of the "Notch Signaling Pathway in Oncology Drug Pipeline Update 2011" report to their offering.
Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 70 companies plus partners developing 67 Notch pathway targeting drugs in 244 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 31 drugs.
This pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 65 different targets. These targets are further categorized on in the software application by 21 classifications of molecular function and with pathway referrals to BioCarta, KEGG and NetPath.
Find and sort drugs by twelve different parameters plus free text search field. Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser, whether it is a single drug profile or an entire search you want have a report of.
This report includes more than 70 principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators. It also contains 67 Notch pathway targeting drugs in development, which have a total of 244 developmental projects in cancer. In addition there are suspended and ceased drugs.
For more information, and a full table of contents, visit http://www.researchandmarkets.com/research/5df897/notch_signaling_pa
How May Drug Pipeline Update Be of Use?
- Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for worldwide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug.